Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

Enzymatica AB: Enzymatica focuses on growth with new recruitment - Anna Söderlund joins as Senior Director Marketing & Sales

Enzymatica

Enzymatica AB (publ) announces today that Anna Söderlund has joined as the new Senior Director Marketing & Sales. With over 25 years of experience in the Life Science industry, where she has held leading roles at global companies such as Pfizer and MSD, Anna brings solid expertise to the company.

- We are very pleased to welcome Anna Söderlund to Enzymatica. We are in an expansive phase with a strong focus on driving sales growth. Anna's long experience, strategic acumen, and commitment will be crucial to our continued success, says Claus Egstrand, CEO of Enzymatica.

Anna Söderlund holds a Master of Science in Economics from Linköping University and has previously successfully worked in key roles in marketing, sales and business development.

- I look forward to joining Enzymatica. ColdZyme has the potential to become the leading brand in the common cold segment in Sweden. Working with a product with such great potential and in such a dynamic company feels incredibly exciting, says Anna Söderlund.

The recruitment of Anna Söderlund strengthens Enzymatica's commitment to further expand and establish itself as a leading player in its segment. Anna Söderlund has taken up her position and is part of Enzymatica's Group Management.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.